The huge discrepancy in U.S. prices compared to those elsewhere is expected to have a major economic impact.

The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump's constantly evolving trade agenda.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Shares of large-cap and large regional banks could be due for some gains over the coming months, according to Keefe, Bruyette & Woods.

Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. drugmaker's respiratory treatments.

Frank Holland breaks down what traders are watching ahead of the new session.

Here are the biggest calls on Wall Street on Wednesday.

Swiss sneaker company On is on a mission to reinvent the traditional running shoe through an unconventional manufacturing process.

Mortgage demand took a big jump higher, as rates continue to fall to their lowest level in three months.

BNY Mellon will be the primary custodian for the Ripple's U.S. dollar-pegged stablecoin reserves going forward, the two companies jointly announced Wednesday.